Search Results 281-290 of 19795 for hemoglobin

  1. Comparing Combinations Of Drugs To Treat Newly Diagnosed Multiple Myeloma (NDMM) When A Stem Cell Transplant Is Not A Medically Suitable Treatment - Mayo Clinic

    - Hemoglobin >= 7 g/dL (must be performed within 28 days prior to registration) - Note: growth factor and transfusion utilization are allowed if cytopenias

  2. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. Enhancing Adaptations To Exercise - Clinical Trials

    Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl); Active coronary artery disease or history of unstable macrovascular ...

  4. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. Blood urea nitrogen (BUN) test - Mayo Clinic

    Learn about the blood urea nitrogen (BUN) test to assess kidney function and what possible results could mean.

  6. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  7. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. Orthopedic Surgery - Clinical trials

    ... hemoglobin levels, 90-day complications, readmission and reoperation. A Study to Evaluate A Patient's Perception of Indwelling Foley Catheters Following ...

  10. A Study To Evaluate The Effectiveness, Safety, Pharmacokinetics And Pharmacodynamics Of Idasanutlin Monotherapy In Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Hemoglobin > 16.5 g/dL in men, > 16.0 g/dL in women OR Hct > 49% in men, > 48% in women, OR other evidence of increased red cell mass. Bone marrow biopsy ...